drugset / Trial / NCT03276026

A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

NCT03276026 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators will track bariatric patients who received sugammadex versus neostigmine in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting / hypoxia episodes.

Timeline

Start
2018-02-12
Primary completion
2018-11-08
Completion
2018-11-08

Outcome

Outcome not reported

Stopped: “PI left the Institution.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 5 mg —
Comparator Sugammadex Other / unclassified 2 mg/kg —
Comparator Sugammadex Other / unclassified 4 mg/kg —